Cargando…
PB.03: Evaluating the role of breast MRI at mid-cycle chemotherapy
Autores principales: | Santosh, D, Uruski, G, Borley, A, Young, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981507/ http://dx.doi.org/10.1186/bcr3505 |
Ejemplares similares
-
Imaging the breast following neoadjuvant chemotherapy: does improvement of imaging findings in the axilla predict pathological response in the breast?
por: Williams, A, et al.
Publicado: (2012) -
PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
por: Halim, M, et al.
Publicado: (2014) -
Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
por: Bansal, GJ, et al.
Publicado: (2015) -
PB.27. Breast screening with MRI in high-risk women
por: Howarth, D, et al.
Publicado: (2014) -
PB.45: Evaluation of a pilot MRI breast surveillance project for young women at high risk of breast cancer
por: De Souza, S, et al.
Publicado: (2013)